PBAC Releases Update on Zoladex Implant Listing
09 Sep 2026
The Pharmaceutical Benefits Advisory Committee (PBAC) has released an update following a special meeting held on 30 July 2026. The meeting focused on the planned removal of the 3.6 mg goserelin implant (Zoladex Implant™) from the Pharmaceutical Benefits Scheme (PBS).
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
Popular Posts
Recent Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy